A modified spacer device for inhalational drug therapy for chronic bronchitis/asthma in laryngectomised patients

Clinical Otolaryngology and Allied Sciences

Volumn 25, Issue 2, 2000, Pages 118-119

  Nandapalan, V ^a,c   Currey, M ^b   Jones, T M ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c FRCS   (United Kingdom)

Author keywords

Inhalational drugs; Laryngectomy; Modified spacer device

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CLINICAL ARTICLE; FACE MASK; HUMAN; LARYNGECTOMY; METERED DOSE INHALER; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ASTHMA; BRONCHITIS; CHRONIC DISEASE; EQUIPMENT DESIGN; HUMANS; LARYNGECTOMY; NEBULIZERS AND VAPORIZERS;

EID: 0034050081     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2000.00324.x     Document Type: Article

References (6)

1. 1 MEEKER D.P. & STELMACH K. (1922). Modification of the spacer device: use in the patient with arthritis or an artificial airway. Chest 102, 1243-1244
2. 2 O'CALLAGHAN C., DRYDEN S., CERT D.N. et al. (1989). Asthma therapy and a tracheostomy. J. Laryngol. Otol. 103, 427-428
3. 3 NAKHLA V. (1997). A home made modification of a spacer device for delivery of bronchodilator or steroid therapy in patients with a tracheostomy. J. Laryngol. Otol 111, 363-365
4. 4 WEBBER P.A. & BROWN A.R. (1984). The use of a conical spacer after laryngectomy. BMJ 288, 1537
5. 5 SUTTON J. (1966). Inhalational devices in the treatment of asthma. Prescriber 7, 67-70
6. 6 HINDLE M. & CHRYSTYN H. (1994). Relative bioavailability of salbutamol to the lung using MDI methods and spacer devices. Thorax 49, 549-553